W. M. Sikov

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

Charles L. Shapiro, Susan Halabi, Vera Hárs et al. · European Journal of Cancer · 2011 · 100 citations

Calgb Trial 79809, Bone Disease, Zoledronic Acid +15

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)

W. M. Sikov, DA Berry, CM Perou et al. · Cancer Research · 2016 · 86 citations

Breast Oncology, Cancer Epidemiology, Overall Survival +14

Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)

W. M. Sikov, DA Berry, CM Perou et al. · Cancer Research · 2013 · 54 citations

Breast Oncology, Pathologic Complete Response, Pathology +17

Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.

Wallace Akerley, W. M. Sikov, F J Cummings et al. · PubMed · 1997 · 34 citations

Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.

Wallace Akerley, Hak Choy, Howard Safran et al. · PubMed · 1997 · 29 citations